Navigation Links
Cytopia Announces Novel Anti-Cancer Drug Development Collaboration
Date:5/9/2008

Boosts Cytopia's development of early pipeline cancer drug candidates

MELBOURNE, Australia, May 9 /PRNewswire-FirstCall/ -- Cytopia Limited (ASX: CYT) today announced that it has entered into an anti-cancer drug discovery and development collaboration with Cancer Therapeutics CRC Pty Ltd. This agreement leverages Cytopia's early stage drug discovery pipeline of kinase inhibitors, a class of targeted therapeutics that is one of the fastest growing segments of the cancer drug market.

Cytopia will retain an option over exclusive commercialization rights for any drug candidates delivered by the collaboration. Should Cytopia choose not to exercise this option, Cancer Therapeutics may proceed with commercialization activities. In the event that all milestones to registration are successfully achieved, both Cancer Therapeutics and Cytopia will share in any partnering revenues, as well as royalty payments from a marketed drug.

Andrew Macdonald, CEO of Cytopia said, "Cytopia's drug discovery engine has generated many opportunities for novel cancer therapies and this innovative partnership gives us the freedom to focus investment on our later stage pipeline while still allowing our very early pipeline to move forward."

"Most importantly, the agreement leaves us with an option to capture the value upside for our investors if a new cancer drug is taken to market."

Under the terms of the collaboration, Cytopia has out-licensed specific proprietary technology to Cancer Therapeutics for an undisclosed kinase enzyme target with potential for treating metastatic cancers. Development of an inhibitor of this particular kinase could have blockbuster potential in the cancer market. Under the project plan,

Cancer Therapeutics will conduct and fund further development of the Cytopia compounds for at least two years. Cancer Therapeutics is a company, formed under the Australian Commonwealth Government's CRC scheme, to discover and develop new
'/>"/>

SOURCE Cytopia Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cytopia Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... and HOUSTON, TX , Feb. 27, ... (TSX-V: EPI) and Bloom Burton & Co. Ltd. ("Bloom ... contractual lock-up (the "Lock-Up") 2,353,130 common shares of the ... originally subject to the Lock-Up. Of the Common Shares ... trading immediately upon release from the Lock-Up while the ...
(Date:2/27/2015)... Feb. 27, 2015  In recognition of Rare Disease ... the global bleeding disorders community, CSL Behring ... units (IUs) of protein therapies to the World Federation ... organization which has worked to improve the lives of ... donation supports the WFH,s Global Alliance for Progress (GAP) ...
(Date:2/27/2015)... , Feb. 27, 2015  Uroplasty, Inc. (NASDAQ: ... and markets innovative proprietary products to treat voiding dysfunctions, ... Annual ROTH Conference on Tuesday, March 10, 2015. ... Reynolds , Chief Financial Officer, will present at 4:00 ... one at the conference at the Ritz Carlton in ...
Breaking Medicine Technology:ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 2CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 3Uroplasty to Participate in the 27th Annual ROTH Conference 2
... , WILMINGTON, Del. ... System is taking a giant leap forward toward a ... Order Entry (CPOE), technology that makes it easier, more efficient ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090407/DC95299LOGO ) , The system goes live on ...
... , HOFFMAN ESTATES, Ill. , Jan. 28 ... Drug Administration (FDA) has given 510(k) marketing clearance to both ... , The DYNA-LINK system features a next-generation stand-alone device that ... is a thoracolumbar plating system that features multiple types of ...
Cached Medicine Technology:Christiana Care Health System Rolls Out Electronic Computerized Provider Order Entry 2
(Date:2/27/2015)... Dr. Andrew Campbell, one of the ... announce the expansion of Quintessa Aesthetic Center with a ... begun seeing patients on February 18, 2015. , According ... a variety of state-of-the-art surgical and non-surgical procedures ... peels, chemical peels, microdermabrasion, ProFractional Laser, Broad Band Light, ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Winter is here, ... on human skin, exposure to snow and ice can be ... also hurt dogs’ paws. The Puppy Store is ready to ... keep their dogs safe in the winter time. , Ice ... vomiting, diarrhea and other symptoms. Ingestion of ice melt products ...
(Date:2/27/2015)... Florida Hospital North Pinellas is being ... Gold Plus hospital. In order to receive the award, ... to all Get With The Guidelines - Stroke Quality ... and achieved 75-percent or higher compliance with six of ... These are reporting initiatives to measure quality of care. ...
(Date:2/27/2015)... February 27, 2015 Healthpointe is ... suffered from injuries or diseases affecting the ... physicians are located throughout Southern California, and are ... to treat conditions related to the upper extremities. ... M. Ashley are board-certified and fully trained in ...
(Date:2/27/2015)... 27, 2015 Mirena IUD lawsuits ( ... allegedly suffered uterine perforations and other serious harm due ... to move forward in the multicounty litigation underway in ... reports. Court records indicate that the proceeding’s 34th ... a Conference convened that same day. (In Re: Mirena ...
Breaking Medicine News(10 mins):Health News:Dr. Andrew Campbell Expands Quintessa Aesthetic Center into Delafield 2Health News:Dr. Andrew Campbell Expands Quintessa Aesthetic Center into Delafield 3Health News:The Puppy Store Helps Dogs Prepare for Harsh Winter Conditions 2Health News:Florida Hospital North Pinellas Receives Get With The Guidelines - Stroke Gold Plus Quality Achievement Award 2Health News:Healthpointe is Now Performing Arthroscopic Surgery Techniques for Elbow, Hand and Wrist Injuries and Diseases, such as certain Ganglion Cysts 2Health News:Mirena Lawsuits Progress in New Jersey with Issuance of New Case Management Order, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Progress in New Jersey with Issuance of New Case Management Order, Bernstein Liebhard LLP Reports 3
... services available for all Minnesotans, MINNEAPOLIS, Feb. 14 ... day such as a birthday or holiday as a ... the perfect day to,quit smoking for that special someone, ... QUITPLAN Services from ClearWay,Minnesota(SM)., Some romantic benefits of ...
... Company Recognized for Outstanding Sales Achievement, PARAMUS, N.J., ... and Earth Balance(R) heart healthy food products,and other established ... Award (MVP) by Refrigerated & Frozen Foods Retailer magazine. ... refrigerated and frozen,food supplier with the largest percentage gain ...
... (Nasdaq: DATA ), a technology company focused ... today reported that it will be,presenting at the ... at the Ritz Carlton in Laguna Niguel, California, ... on Wednesday afternoon,February 20th at 2:30 P.M., Pacific ...
... Today Digital Healthcare,Systems filed to enjoin the Ohio ... of Jobs and Family Services (ODJFS),regarding a state-issued ... in health insurance administration that settles which insurers,are ... Healthcare, headquartered in Cleveland, filed the petition in,the ...
... in scorpion venom that may hold the key to ... , In the December 28 issue of the Journal ... how this novel peptide, called GaTx1, can control the ... interacting with a crucial chloride channel. This research was ...
... new water purification,technology by Reliance Products L.P., one ... products, and Procter & Gamble (NYSE: PG ... United States. The,product, PUR(TM) Purifier of Water ( ... designed for outdoor recreation,and emergency preparedness use. PUR ...
Cached Medicine News:Health News:QUITPLAN(R) Services Can Help Make Valentine's Day Smoke-Free 2Health News:QUITPLAN(R) Services Can Help Make Valentine's Day Smoke-Free 3Health News:Smart Balance(R) Named MVP in Refrigerated & Frozen Foods Retailer Product Lineup 2Health News:DATATRAK to Present at the Roth Capital Partners 20th Annual Orange County Stock Conference 2Health News:DATATRAK to Present at the Roth Capital Partners 20th Annual Orange County Stock Conference 3Health News:Digital Healthcare Files to Enjoin Two State of Ohio Departments; Charges Bid-Steering and Breach of Agreement in Program to Control Medicaid Overpayment of Insurance Claims 2Health News:Peptide discovered in scorpion venom may hold key to secretory diseases 2Health News:Peptide discovered in scorpion venom may hold key to secretory diseases 3Health News:New Water Purification Product from Reliance Products and Procter & Gamble now Available in Retail Stores 2Health News:New Water Purification Product from Reliance Products and Procter & Gamble now Available in Retail Stores 3
... The HOPE continuous nebulizer is improved CNBT technology, ... of remixing SVNs every 15 minutes. HOPE allows ... to eight hours. Heliox administration couldn't be easier, ... tank of Heliox, you can turn the HOPE ...
... Thera-Mist® Air Entrainment Nebulizers deliver particulate ... range for your chronic secretion patients. For ... with your existing supply of sterile water., ... operates at FiO2's of 20-50% with a ...
Rotary Piston Mini Nebulizer...
Lumitex® LightMat® Surgical Illuminator improves visualization in deep cavity surgery. Flexible and malleable, it attaches easily to most retractors, bringing bright, cool area lighting where...
Medicine Products: